Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Ljungberg

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Expert Review of Vaccines|April 2, 2008
HIV vaccine development: the myth of Sisyphus modernized?Karl Ljungberg
Expert Review of Vaccines|October 2, 2014
Self-replicating alphavirus RNA vaccinesKarl Ljungberg, Peter Liljeström
Vaccines|December 9, 2020
DNA Vaccine Development at Pre- and Post-Operation Warp SpeedKarl Ljungberg, Maria Isaguliants
Lakartidningen|October 4, 2008
[Therapeutic vaccines against cancer and infectious diseases. Great possibilities in the research--small clinical progress so far]Rolf Kiessling, Karl Ljungberg, Alexander Von Gabain
Scientific Reports|December 4, 2020
Infectious RNA vaccine protects mice against chikungunya virus infectionInga Szurgot, Karl Ljungberg, Beate M Kümmerer, et al.
AIDS (London, England)|April 21, 2004
Primary murine cells as a model for HIV-1 infectionLars H Lund, Karl Ljungberg, Britta Wahren, et al.
Molecular Pharmaceutics|February 6, 2007
Vaccine delivery methods using viral vectorsAndreas Bråve, Karl Ljungberg, Britta Wahren, et al.
Plos One|January 13, 2012
Intradermal electroporation of naked replicon RNA elicits strong immune responsesDaniel X Johansson, Karl Ljungberg, Maria Kakoulidou, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2014
Intradermal electroporation of RNAMaria L Knudsen, Karl Ljungberg, Peter Liljeström, et al.
Virology|November 14, 2002
Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypesKarl Ljungberg, Erik Rollman, Lars Eriksson, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Expert Review of Vaccines|April 2, 2008
HIV vaccine development: the myth of Sisyphus modernized?Karl Ljungberg
Expert Review of Vaccines|October 2, 2014
Self-replicating alphavirus RNA vaccinesKarl Ljungberg, Peter Liljeström
Vaccines|December 9, 2020
DNA Vaccine Development at Pre- and Post-Operation Warp SpeedKarl Ljungberg, Maria Isaguliants
Lakartidningen|October 4, 2008
[Therapeutic vaccines against cancer and infectious diseases. Great possibilities in the research--small clinical progress so far]Rolf Kiessling, Karl Ljungberg, Alexander Von Gabain
Scientific Reports|December 4, 2020
Infectious RNA vaccine protects mice against chikungunya virus infectionInga Szurgot, Karl Ljungberg, Beate M Kümmerer, et al.
AIDS (London, England)|April 21, 2004
Primary murine cells as a model for HIV-1 infectionLars H Lund, Karl Ljungberg, Britta Wahren, et al.
Molecular Pharmaceutics|February 6, 2007
Vaccine delivery methods using viral vectorsAndreas Bråve, Karl Ljungberg, Britta Wahren, et al.
Plos One|January 13, 2012
Intradermal electroporation of naked replicon RNA elicits strong immune responsesDaniel X Johansson, Karl Ljungberg, Maria Kakoulidou, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 11, 2014
Intradermal electroporation of RNAMaria L Knudsen, Karl Ljungberg, Peter Liljeström, et al.
Virology|November 14, 2002
Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypesKarl Ljungberg, Erik Rollman, Lars Eriksson, et al.
Pageof 4